Overview

Clinical Study Assessing the Efficacy and Safety of Macitentan in Fontan-palliated Subjects

Status:
Completed
Trial end date:
2021-07-26
Target enrollment:
Participant gender:
Summary
The primary objective is to assess the effect of macitentan 10 mg as compared to placebo on exercise capacity through cardiopulmonary exercise testing.
Phase:
Phase 3
Details
Lead Sponsor:
Actelion
Treatments:
Macitentan